Miramar Labs

High-Level Overview

Miramar Labs was a medical device company founded in 2006 and headquartered in Santa Clara, California, specializing in dermatology treatments using proprietary microwave-based miraWave™ technology. The company developed the miraDry system, the only FDA-cleared non-invasive device for reducing underarm sweat, odor, and permanently reducing hair of all colors, targeting aesthetic conditions like hyperhidrosis with significant unmet clinical needs.[1][2][6] It served aesthetic physicians and patients seeking effective, clinically proven treatments, achieving strong growth with over 90,000 treatments sold, 900+ systems installed worldwide, and $20 million in 2016 revenue (up 19% year-over-year) before its acquisition by Sientra, Inc. in July 2017 for $34 million following $10 million in APO financing.[1][2]

Origin Story

Miramar Labs emerged in 2006 as a global medical device innovator focused on dermatology, led by CEO and President Michael Kleine, who guided the company through development and commercialization of its core technology.[1][2] The idea stemmed from addressing everyday aesthetic issues like bothersome underarm sweat affecting hundreds of millions, backed by rigorous clinical research to pioneer microwave energy applications in aesthetics.[1][2][7] Key milestones included FDA clearance for miraSmooth (permanent underarm hair reduction of all colors) and rapid market traction, culminating in the 2017 acquisition by Sientra, which Kleine hailed as a path to scale sales and marketing via Sientra's infrastructure.[2][6]

Core Differentiators

• Proprietary miraWave™ Technology: Harnessed microwave energy for precise, non-invasive treatments targeting sweat glands and hair follicles, delivering permanent results unsupported by competitors.[1][2][3][7]
• FDA-Cleared Efficacy and Safety: Sole device cleared for underarm sweat, odor, and hair reduction (all colors); proven via clinical trials with high patient satisfaction and over 90,000 procedures by 2017.[2][6]
• Commercial Track Record: Rapid adoption with 900+ systems installed globally and 19% revenue growth to $20 million in 2016, emphasizing scalability for aesthetic practices.[1][2]
• Clinical Focus: Prioritized unmet needs in dermatology, supported by independent research, setting it apart in a market dominated by less permanent laser or energy-based alternatives.[1][5]

Role in the Broader Tech Landscape

Miramar Labs rode the wave of the aesthetics medtech boom in the mid-2010s, capitalizing on rising demand for non-surgical dermatology solutions amid growing consumer interest in body contouring and hyperhidrosis treatments.[2] Timing was ideal post-FDA clearances, aligning with market forces like expanding aesthetic physician networks and patient preference for quick, efficacious procedures over invasive options.[1][6] The company influenced the ecosystem by validating microwave technology as a high-margin, recurring-revenue model for devices, paving the way for Sientra's portfolio expansion into non-implant aesthetics and demonstrating medtech's potential for attractive exits in underserved niches.[2]

Quick Take & Future Outlook

Post-2017 acquisition, Miramar Labs' miraDry integrated into Sientra's (now part of broader aesthetics players) lineup, likely sustaining growth through enhanced distribution amid ongoing trends like minimally invasive beauty tech and personalized dermatology.[2] Evolving demands for sweat and hair management—fueled by wellness culture and climate-driven needs—position miraDry for further adoption, potentially via AI-enhanced systems or expanded indications. Its legacy underscores how targeted medtech innovation can disrupt aesthetics, evolving from standalone pioneer to a scaled platform influencing physician practices globally—echoing its founding mission to transform everyday dermatologic challenges.[1][2]